True Wealth Design’s Tvardi Therapeutics TVRD Stock Holding History
Bought
Maintained
Sold
Other funds holding TVRD
True Wealth Design's TVRD Position: Q3 2026 in Review
True Wealth Design sold out of Tvardi Therapeutics (TVRD) in Q3 2026, closing a stake of 2 shares — an estimated $4 sold.
True Wealth Design first reported a position in TVRD in Q1 2026 and held it in 2 quarters. The position peaked at $29 in Q1 2026. 62 funds tracked by Wall St. Rank hold TVRD as of Q3 2026.
- True Wealth Design reported no remaining Tvardi Therapeutics position as of Q3 2026 after selling out during the quarter.
- True Wealth Design sold 2 Tvardi Therapeutics shares in Q3 2026, an estimated $4.
- True Wealth Design first reported a position in Tvardi Therapeutics in Q1 2026 and held it in 2 quarters.
- True Wealth Design's Tvardi Therapeutics position peaked at $29 in Q1 2026.
- 62 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q3 2026.
Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.